Lates News

Every economic AI news, Open Source Securities issued a research report on April 26, giving Yifeng Pharmacy (603939.SH) a "buy" rating. The main reasons for the rating include: 1) stable and improved operating performance, maintaining a "buy" rating; 2) retail business stabilizing and growing, franchise and distribution business growing rapidly; 3) store adjustments nearing completion, restart of growth, actively expanding online and offline layout to accept hospital prescription outflow. (Daily Economic News)